Eye drop showdown: which lifts droopy eyelids better?
NCT ID NCT07390578
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study compares two FDA-approved eye drops, Upneeq and Lumify, to see which one better lifts droopy eyelids in adults with acquired ptosis. Fifty participants will receive a single drop of each medication on separate visits, and eyelid height will be measured after about an hour. The goal is to find out which drop provides a better temporary lift.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Oxymetazoline 0.1% (Upneeq) and brimonidine 0.025% (Lumify) eye drops
- What this could lead to
- If this trial shows one drop works better, it could help doctors choose the most effective option for temporarily lifting droopy eyelids.
- What could go wrong
- This is a small, early-phase study with only 50 people. The effect is temporary and may not work for everyone. Eye irritation is possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACQUIRED PTOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.